This application note outlines the use of the Symcel calScreener™ in combination with Synthetic CF Sputum Media (SCFM) to model cystic fibrosis-related biofilms. This approach provides real-time, in situ analysis of biofilm kinetics, offering insights into treatment efficacy under clinically relevant conditions, and addressing limitations of conventional biofilm models.
